Concepedia

Publication | Open Access

Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept

65

Citations

12

References

2021

Year

Abstract

Additional measures need to be explored to protect kidney transplant recipients taking belatacept. Best safety practices should be continued despite vaccination among this population.

References

YearCitations

Page 1